Life sciences stocks fall on NIH funding concerns
Source: SeekingAlpha
2025-01-23 12:55:36 ET
More on Illumina, Pacific Biosciences of California, etc.
- Illumina, Inc. (ILMN) 43rd Annual JPMorgan Healthcare Conference - (Transcript)
- 10x Genomics: Struggling Amid Operational Challenges
- Illumina And Grail In 2025? Grounds For Optimism, If Mistakes Aren't Repeated
- Illumina reports preliminary Q4 results, provides 2025 expectations
- PacBio announces preliminary Q4 revenue of $39.2M
Read the full article on Seeking Alpha
For further details see:
Life sciences stocks fall on NIH funding concerns
Marker Therapeutics Inc.
NASDAQ: MRKR
MRKR Trading
-2.55% G/L:
$1.335 Last:
43,554 Volume:
$1.36 Open:
MRKR Latest News
February 18, 2026 08:00:00 am
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
January 26, 2026 07:00:00 am
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics' MAR-T Cell Technology
January 05, 2026 07:00:00 am
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
November 14, 2025 07:00:00 am
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
MRKR Stock Data
$25,759,981
15,372,623
3.36%
21
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
